Your browser doesn't support javascript.
loading
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Statland, Jeffrey M; Moore, Dan; Wang, Yunxia; Walsh, Maureen; Mozaffar, Tahseen; Elman, Lauren; Nations, Sharon P; Mitsumoto, Hiroshi; Fernandes, J Americo; Saperstein, David; Hayat, Ghazala; Herbelin, Laura; Karam, Chafic; Katz, Jonathan; Wilkins, Heather M; Agbas, Abdulbaki; Swerdlow, Russell H; Santella, Regina M; Dimachkie, Mazen M; Barohn, Richard J.
Afiliación
  • Statland JM; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
  • Moore D; The Forbes Norris MDA/ALS Research Center, California Pacific Medical Center, San Francisco, California, USA.
  • Wang Y; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
  • Walsh M; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
  • Mozaffar T; Department of Neurology, University of California, Irvine, Irvine, California, USA.
  • Elman L; Department of Neurology, University of Pennsylvania, Philadelphia, Pennslyvania, USA.
  • Nations SP; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Mitsumoto H; Department of Neurology, Columbia University, New York, New York, USA.
  • Fernandes JA; Department of Neurology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Saperstein D; Phoenix Neurological Associates, Phoenix, Arizona, USA.
  • Hayat G; Department of Neurology, St. Louis University, St. Louis, Missouri, USA.
  • Herbelin L; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
  • Karam C; Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA.
  • Katz J; The Forbes Norris MDA/ALS Research Center, California Pacific Medical Center, San Francisco, California, USA.
  • Wilkins HM; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
  • Agbas A; Department of Biosciences, Kansas City University of Medicine and Bioscience, Kansas City, Missouri, USA.
  • Swerdlow RH; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
  • Santella RM; Department of Neurology, Columbia University, New York, New York, USA.
  • Dimachkie MM; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
  • Barohn RJ; Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 2012, Kansas City, Kansas, 66160, USA.
Muscle Nerve ; 59(2): 201-207, 2019 02.
Article en En | MEDLINE | ID: mdl-30192007
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Esclerosis Amiotrófica Lateral / Indanos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Muscle Nerve Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Esclerosis Amiotrófica Lateral / Indanos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Muscle Nerve Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos